OIRA Conclusion of EO 12866 Regulatory Review


RIN: 0930-ZA08         View EO 12866 Meetings Received Date: 04/14/2021 
Title: Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder 
Agency/Subagency: HHS / SAMHSA   Stage: Notice 
Concluded Action: Consistent with Change  Concluded Date: 04/22/2021 
Legal Deadline: None  Economically Significant: No 
Publication Date:   Unfunded Mandates: No 
Major: No  Related To Homeland Security: No 
Regulatory Flexibility Analysis Required: No  Small Entities Affected: Businesses, Organizations 
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No